7) Therapeutics
Abstract
Respiratory and Systemic: Supports investigation of the systemic host response to chemical warfare agent (CWA) injury via all routes of exposure, with emphasis on the respiratory system and chronic effects of exposure. Develops effective practical field and clinic management strategies, and physical and pharmacological interventions to treat the injury processes. Designed to support eventual Food and Drug Administration (FDA) licensure of new compounds or new indications for licensed products for use in the treatment of chemical warfare casualties.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2012
- Source ID
- acf61cd79b0f5507fb21295e2d14ed82